Biotech gainers today were led by Virax Biolabs on its agreement with Fosun Diagnostics and Forte Biosciences after reporting positive vitiligo data, alongside Connect Biopharma on a key near-term catalyst. SANUWAVE Health was also higher despite recently lowering its SEC-related disclosure (details truncated). Net impact appears stock-specific rather than sector-wide.
Biotech gainers today were led by Virax Biolabs on its agreement with Fosun Diagnostics and Forte Biosciences after reporting positive vitiligo data, alongside Connect Biopharma on a key near-term catalyst. SANUWAVE Health was also higher despite recently lowering its SEC-related disclosure (details truncated). Net impact appears stock-specific rather than sector-wide.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
